Overactive Bladder Treatment Market Size

Overactive Bladder Treatment Market size was over USD 5.17 billion in 2024 and is projected to cross USD 11.8 billion by the end of 2037, growing at more than 6.7% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of overactive bladder treatment is estimated at USD 5.44 billion.

The reason behind the growth is impelled by the growing number of pregnancies. Women go through hormonal changes during pregnancy, which may compromise bladder control and cause symptoms of overactive bladder. The hormone progesterone in particular may encourage bladder muscle relaxation, resulting in increased frequency and urgency of urinating.

The growing inclination toward minimally invasive procedures is believed to fuel the market growth. The need for a shorter hospital stay, less discomfort, and fewer complications has increased the preference for minimally invasive surgery among the general public worldwide. Nonpharmacological treatments such as oral medications have been found to lessen the signs and improve bladder function by strengthening the pelvic floor and altering behavior.

In addition, techniques including neuromodulation, sacral nerve stimulation, and percutaneous tibial nerve stimulation are among the minimally invasive procedures which have gained popularity since they can manage overactive bladder symptoms in patients without the requirement of any surgery. According to research, over 12 million laparoscopic procedures are performed across the globe every year.